REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Vipharm S.A. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Vipharm S.A. Profile Updated: September 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Vipharm S.A. is a company in Poland, with a head office in Ozarow Mazowiecki. The company operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on October 04, 2001. The total number of employees is currently 100 (2010). The latest financial highlights indicate a net sales revenue increase of 6.24% in 2023. Its total assets grew by 23.37% over the same period. The net profit margin of Vipharm S.A. increased by 6.28% in 2023.

Headquarters
Ul. A. I F. Radziwillow 9
Ozarow Mazowiecki; Mazowieckie; Postal Code: 05-850

Contact Details: Purchase the Vipharm S.A. report to view the information.

Website: http://www.vipharm.pl

Basic Information
Total Employees:
Purchase the Vipharm S.A. report to view the information.
Outstanding Shares:
Purchase the Vipharm S.A. report to view the information.
Registered Capital:
Purchase the Vipharm S.A. report to view the information.
Financial Auditors:
Purchase the Vipharm S.A. report to view the information.
Incorporation Date:
October 04, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Vipharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
6.24%▲
Total operating revenue
21.85%▲
Operating profit (EBIT)
187.94%▲
EBITDA
127.56%▲
Net Profit (Loss) for the Period
1325.71%▲
Total assets
23.37%▲
Total equity
8.78%▲
Operating Profit Margin (ROS)
9.18%▲
Net Profit Margin
6.28%▲
Return on Equity (ROE)
7.45%▲
Debt to Equity Ratio
11.68%▲
Quick Ratio
-0.29%▼
Cash Ratio
-0.05%▼

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
Maco Productions Polonia Sp. z o.o.
 
Orifarm Manufacturing Poland Sp. z o.o.
Instytut Biotechnologii Surowic I Szczepionek Biomed S.A. - Skrot Firmy Ibss Biomed S.A.
 
Synoptis Industrial Sp. z o.o.
Master Pharm S.A.
 
Exim Pharma Sp. z o.o.
"Symphar" Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo